Correlation Between Phio Pharmaceuticals and Cardio Diagnostics
Can any of the company-specific risk be diversified away by investing in both Phio Pharmaceuticals and Cardio Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phio Pharmaceuticals and Cardio Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Phio Pharmaceuticals Corp and Cardio Diagnostics Holdings, you can compare the effects of market volatilities on Phio Pharmaceuticals and Cardio Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phio Pharmaceuticals with a short position of Cardio Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phio Pharmaceuticals and Cardio Diagnostics.
Diversification Opportunities for Phio Pharmaceuticals and Cardio Diagnostics
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between Phio and Cardio is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Phio Pharmaceuticals Corp and Cardio Diagnostics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardio Diagnostics and Phio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phio Pharmaceuticals Corp are associated (or correlated) with Cardio Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardio Diagnostics has no effect on the direction of Phio Pharmaceuticals i.e., Phio Pharmaceuticals and Cardio Diagnostics go up and down completely randomly.
Pair Corralation between Phio Pharmaceuticals and Cardio Diagnostics
Given the investment horizon of 90 days Phio Pharmaceuticals Corp is expected to under-perform the Cardio Diagnostics. But the stock apears to be less risky and, when comparing its historical volatility, Phio Pharmaceuticals Corp is 1.54 times less risky than Cardio Diagnostics. The stock trades about -0.05 of its potential returns per unit of risk. The Cardio Diagnostics Holdings is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 198.00 in Cardio Diagnostics Holdings on August 29, 2024 and sell it today you would lose (167.00) from holding Cardio Diagnostics Holdings or give up 84.34% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Phio Pharmaceuticals Corp vs. Cardio Diagnostics Holdings
Performance |
| Timeline |
| Phio Pharmaceuticals Corp |
| Cardio Diagnostics |
Phio Pharmaceuticals and Cardio Diagnostics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Phio Pharmaceuticals and Cardio Diagnostics
The main advantage of trading using opposite Phio Pharmaceuticals and Cardio Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phio Pharmaceuticals position performs unexpectedly, Cardio Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardio Diagnostics will offset losses from the drop in Cardio Diagnostics' long position.| Phio Pharmaceuticals vs. Zura Bio Limited | Phio Pharmaceuticals vs. Immix Biopharma | Phio Pharmaceuticals vs. Cns Pharmaceuticals | Phio Pharmaceuticals vs. ZyVersa Therapeutics |
| Cardio Diagnostics vs. Eliem Therapeutics | Cardio Diagnostics vs. Scpharmaceuticals | Cardio Diagnostics vs. Milestone Pharmaceuticals | Cardio Diagnostics vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |